Stocks Health care SOLV
NYSE · Health careSolventum Corp (SOLV)
Solventum Corp brought in $8.2B of revenue over the twelve months to September 30, 2026, down 2.8% from a year earlier. Net income was $156M, a net margin of 1.9%. In fiscal 2025 capital spending exceeded operating cash flow by $10M. At September 30, 2026 it held $451M in cash against $4.6B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Solventum Corp
- Net worth
- Solventum Corp has a market value (market cap) of $15.1B at the latest share price, and shareholders' equity of $4.8B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $8.3B (+0.9% year on year), with net income of $1.6B. Over the 12 months to September 30, 2026: revenue $8.2B, net income $156M.
- Cash flow
- In fiscal 2025 operations brought in $369M of cash; after $379M of capital spending, free cash flow was -$10M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Solventum Corp's next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Solventum Corp does
Solventum Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker SOLV.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $8.3B | $1.6B | $8.88 | -$10M |
| 2024 | $8.3B | $479M | $2.76 | $805M |
| 2024 | $8.2B | $1.3B | $7.79 | $1.6B |
| 2022 | $8.1B | $1.3B | $7.78 | $1.4B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where SOLV ranks in Health care
Latest SEC filings
What Solventum Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 7% to $1.9B versus the same quarter last year; diluted EPS -$0.07 versus $7.22.
- November 5, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 2.2% to $2.2B versus the same quarter last year; diluted EPS $0.53 versus $0.51.
- August 5, 2026
- August 5, 2026
- July 20, 2026
- June 5, 2026Other event 8-K
- May 29, 2026
- May 27, 2026
- May 20, 2026
Insider trades
What the people running Solventum Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 1, 2026 | Hanson Bryan CChief Executive Officer, Director | Exercised options | 67,261 | - |
| September 1, 2026 | Hanson Bryan CChief Executive Officer, Director | Shares withheld for tax | 26,468 | $2.4M |
| May 13, 2026 | Hanson Bryan CChief Executive Officer, Director | Exercised options | 34,315 | - |
| May 13, 2026 | Hanson Bryan CChief Executive Officer, Director | Shares withheld for tax | 13,503 | $1M |
| May 13, 2026 | McMillan Wayde D.Chief Financial Officer | Exercised options | 9,503 | - |
| May 13, 2026 | McMillan Wayde D.Chief Financial Officer | Shares withheld for tax | 4,404 | $327.7K |
| May 13, 2026 | Kirberger Marcela A.Chief Legal Affairs Officer | Exercised options | 4,488 | - |
| May 13, 2026 | Kirberger Marcela A.Chief Legal Affairs Officer | Shares withheld for tax | 1,952 | $145.2K |
Who owns SOLV
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Independent Franchise Partners, LLP13G, passive | 8.85% | January 27, 2026 |
| Vanguard Capital Management13G, passive | 6.27% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 878 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Independent Franchise Partners LLP | 16,170,038 | +436,543 |
| BlackRock, Inc. | 9,761,863 | -717,109 |
| Vanguard Capital Management LLC | 9,624,829 | +22,880 |
| Trian Fund Management, L.P. | 8,236,753 | 0 |
| Vanguard Portfolio Management LLC | 6,328,641 | -61,723 |
| Davis Selected Advisers | 6,307,729 | -22,596 |
| State Street Corp | 5,639,230 | -768,250 |
| Geode Capital Management, LLC | 4,910,624 | +158,364 |
| Boston Partners | 4,037,963 | +123,872 |
| Invesco Ltd. | 3,309,915 | -479,968 |
| Fmr LLC | 2,079,141 | +209,105 |
| State Farm Mutual Automobile Insurance Co | 2,069,279 | 0 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | 1,945,121 | -475,125 |
| Dimensional Fund Advisors LP | 1,817,658 | +1,042,975 |
| Madison Avenue Partners, LP | 1,741,221 | -134,515 |
| Norges Bank | 1,713,676 | new |
| Morgan Stanley | 1,533,215 | -229,792 |
| Charles Schwab Investment Management Inc | 1,522,657 | +3,143 |
| Northern Trust Corp | 1,387,579 | -151,826 |
| Bank of America Corp | 1,291,866 | -140,914 |
Insiders
18 insiders reported holding 435,705 shares in total, about $38.5M at the last price.
| Holder | Shares |
|---|---|
| Hanson Bryan CChief Executive Officer, Director | 185,515 |
| McMillan Wayde D.Chief Financial Officer | 48,637 |
| Landucci AmyChief Information Officer | 39,888 |
| Harrington Paul SChief Supply Chain Officer | 20,452 |
| Cox Carrie SmithDirector | 16,400 |
| Kirberger Marcela A.Chief Legal Affairs Officer | 13,540 |
| Gomez Tammy LChief Human Resources Officer | 13,362 |
| Wendell Amy McBrideDirector | 10,422 |
| Mily ElizabethDirector | 9,009 |
| Wilson Darryl L.Director | 8,947 |
Questions about SOLV
What does Solventum Corp do?
Solventum Corp is a company in the Health care sector, listed on NYSE as SOLV. Its shares trade on NYSE under the ticker SOLV.
What is Solventum Corp's net worth?
Solventum Corp has a market value (market cap) of $15.1B at the latest share price, and shareholders' equity of $4.8B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Solventum Corp profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $156M on revenue of $8.2B, a net margin of 1.9%.
How much revenue does Solventum Corp make?
Over the twelve months to September 30, 2026 Solventum Corp reported revenue of $8.2B. That is 2.8% less than a year earlier.
When did Solventum Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Solventum Corp's next earnings report?
Solventum Corp's next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare SOLV with
Follow SOLV
Get an email when Solventum Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Solventum Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.